secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK:        0000879407
Form:       8-K/A
Filed at:   2024-03-18T23:59:59+00:00
Accession:  0001628280-24-011557
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arrowhead appoints Hongbo Lu to board; board expands to eight, effective March 15
--------------------------------------------------------------------------------

- Hongbo Lu appointed to Arrowhead Board; board expanded from seven to eight, effective March 15, 2024.
- Dr. Lu receives sign-on RSU grant of $761,666, vesting over three years.
- Dr. Lu will receive standard non-employee director compensation as described in the 2024 proxy statement.
- Dr. Lu has no family relationships with executives and no material interest in any related-party transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879407/000162828024011557/0001628280-24-011557-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879407/000162828024011557/arwr-20240221.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-011557

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer